SCIATIC DENERVATION-INDUCED SKELETAL MUSCLE ATROPHY IS ASSOCIATED WITH PERSISTENT INFLAMMATION AND INCREASED MORTALITY DURING SEPSIS

ABSTRACT Background: Patients with underlying skeletal muscle atrophy are likely to develop aggravated sepsis. However, no study has experimentally verified the association between the prognosis of sepsis and muscle atrophy, and the mechanism of aggravation of sepsis under muscle atrophy remains unclear. In this study, we investigated the effect of skeletal muscle atrophy induced by sciatic denervation (DN), an experimental muscle atrophy model, on sepsis prognosis. Methods: Skeletal muscle atrophy was induced by DN of the sciatic nerve in C57BL/6J male mice. Cecal ligation and puncture (CLP) was performed to induce sepsis. Results: The survival rates of the sham and DN groups 7 days after CLP were 63% and 35%, respectively, wherein an approximately 30% reduction was observed in the DN group (P < 0.05, vs. sham-CLP). The DN group had a higher bacterial count in the blood 48 h after CLP (P < 0.05, vs. sham-CLP). Notably, NOx (a metabolite of nitric oxide) concentrations in DN mice were higher than those in sham mice after CLP (P < 0.05, vs. sham-CLP), whereas serum platelet levels were lower 48 h after CLP (P < 0.05, vs. sham-CLP). In organ damage analysis, DN mice presented increased protein expression of the kidney injury molecule (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL), a kidney injury marker, after CLP (NGAL 48 h after CLP, P < 0.05, vs. sham-CLP; KIM-1 24 h after CLP, P < 0.01, vs. sham-CLP). Furthermore, nitro tyrosine levels in the kidneys of DN mice were higher 48 h after CLP compared with those in sham-CLP mice, indicating the accumulation of nitrative stress (P < 0.05, vs. sham-CLP). Serum cytokine levels were increased in both groups after CLP, but decreased in the sham group 48 h after CLP and remained consistently higher in the DN group (tumor necrosis factor [TNF]-α: P < 0.05, sham-CLP vs. DN-CLP; interleukin (IL)-1β: P < 0.01, sham-CLP vs. DN-CLP; IL-6: P < 0.05, DN vs. DN-CLP; IL-10: P < 0.05, sham-CLP vs. DN-CLP). Conclusions: We verified that skeletal muscle atrophy induced by DN is associated with poor prognosis after CLP-induced sepsis. Importantly, mice with skeletal muscle atrophy presented worsening sepsis prognosis at late onset, including prolonged infection, persistent inflammation, and kidney damage accumulation, resulting in delayed recovery.

[1]  Shuangping Zhao,et al.  Sarcopenia and Mortality Risk of Patients with Sepsis: A Meta-Analysis , 2022, International journal of clinical practice.

[2]  L. Moldawer,et al.  The impact of sarcopenia and acute muscle mass loss on long‐term outcomes in critically ill patients with intra‐abdominal sepsis , 2021, Journal of cachexia, sarcopenia and muscle.

[3]  J. Andersen,et al.  Muscle-nerve communication and the molecular assessment of human skeletal muscle denervation with aging. , 2021, American journal of physiology. Cell physiology.

[4]  Wen-qing Xie,et al.  Mouse models of sarcopenia: classification and evaluation , 2021, Journal of cachexia, sarcopenia and muscle.

[5]  J. Ehmsen,et al.  Cellular and molecular features of neurogenic skeletal muscle atrophy , 2020, Experimental Neurology.

[6]  A. Hotz-Wagenblatt,et al.  Skeletal muscle antagonizes antiviral CD8+ T cell exhaustion , 2020, Science Advances.

[7]  Niranjan Kissoon,et al.  Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study , 2020, The Lancet.

[8]  S. Meuth,et al.  Skeletal muscle as potential central link between sarcopenia and immune senescence , 2019, EBioMedicine.

[9]  R. Gómez,et al.  Platelets Promote Macrophage Polarization toward Pro-inflammatory Phenotype and Increase Survival of Septic Mice. , 2019, Cell reports.

[10]  Tadaaki Yamada,et al.  Association of Sarcopenia with and Efficacy of Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer , 2019, Journal of clinical medicine.

[11]  J. Vincent,et al.  Mechanisms and treatment of organ failure in sepsis , 2018, Nature Reviews Nephrology.

[12]  G. Regolisti,et al.  Recent advances in the pathogenetic mechanisms of sepsis-associated acute kidney injury , 2018, Journal of Nephrology.

[13]  F. Venet,et al.  Advances in the understanding and treatment of sepsis-induced immunosuppression , 2018, Nature Reviews Nephrology.

[14]  D. Gabrilovich,et al.  Myeloid-derived suppressor cells coming of age , 2018, Nature Immunology.

[15]  Derek C. Angus,et al.  Enhancing Recovery From Sepsis: A Review , 2018, JAMA.

[16]  R. De Gasperi,et al.  Denervation-related alterations and biological activity of miRNAs contained in exosomes released by skeletal muscle fibers , 2017, Scientific Reports.

[17]  M. Netea,et al.  The immunopathology of sepsis and potential therapeutic targets , 2017, Nature Reviews Immunology.

[18]  M. Otagiri,et al.  Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1 , 2016, Scientific Reports.

[19]  A. Zwinderman,et al.  Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients. , 2016, Blood.

[20]  S. Inoue,et al.  Sepsis induces incomplete M2 phenotype polarization in peritoneal exudate cells in mice , 2016, Journal of Intensive Care.

[21]  Y. Maehara,et al.  Profile of plasma amino acids values as a predictor of sepsis in patients following living donor liver transplantation: Special reference to sarcopenia and postoperative early nutrition , 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

[22]  M. Otagiri,et al.  Pleiotropic Effects of Levofloxacin, Fluoroquinolone Antibiotics, against Influenza Virus-Induced Lung Injury , 2015, PloS one.

[23]  K. Hozumi,et al.  Persistent inflammation and T cell exhaustion in severe sepsis in the elderly , 2014, Critical Care.

[24]  Q. Shu,et al.  Myeloid-Derived Suppressor Cells in Sepsis , 2014, BioMed research international.

[25]  Chibeza C. Agley,et al.  Acute skeletal muscle wasting in critical illness. , 2013, JAMA.

[26]  R. Hotchkiss,et al.  Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. , 2013, The Lancet. Infectious diseases.

[27]  M. Sandri,et al.  Cellular and molecular mechanisms of muscle atrophy , 2013, Disease Models & Mechanisms.

[28]  M. Rose,et al.  Quality of life and measures of quality of life in patients with neuromuscular disorders , 2012, Muscle & nerve.

[29]  L. Moldawer,et al.  Persistent inflammation and immunosuppression: A common syndrome and new horizon for surgical intensive care , 2012, The journal of trauma and acute care surgery.

[30]  John D. Storey,et al.  A genomic storm in critically injured humans , 2011, The Journal of experimental medicine.

[31]  L. Moldawer,et al.  Cecal Ligation and Puncture , 2010, Current protocols in immunology.

[32]  D. Denhardt,et al.  Osteopontin regulates hindlimb-unloading-induced lymphoid organ atrophy and weight loss by modulating corticosteroid production , 2007, Proceedings of the National Academy of Sciences.

[33]  M. Heiman,et al.  Quantitative magnetic resonance (QMR) method for bone and whole-body-composition analysis , 2003, Analytical and bioanalytical chemistry.

[34]  Thomas D. Schmittgen,et al.  Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .